Entity family
Clinical therapies and care approaches used to manage a condition. Examples include immunotherapy, radiotherapy, rehabilitation.
Showing 1,381–1,440 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.
…Background Chimeric antigen receptor (CAR) T-cell therapy has revolutionized cancer immunotherapy for hematological malig…
…Background Immune checkpoint blockade (ICB) therapy has revolutionized cancer treatment but remains effective only …
…mples from 29 melanoma patients (70 samples total) treated with anti-PD-1 therapy at the Huntsman Cancer Institute. Using a 43-marker mass cytome…
…Background Multispecific antibody cancer therapies and other Ab-based therapies such as antibody-drug conjugates (…
…Background Chimeric antigen receptor (CAR) T therapies have transformed the treatment options for patients with hemato…
…ground Existing biomarkers used to predict clinical response to anti-PD1 therapy are suboptimal. Here, we report on a novel assay, known as the …
…t (TME) plays a crucial role in determining patient response to cancer immunotherapies. Cellular therapies, immune checkpoint inhibitors, and other mo…
… intratumor CD8+ T cell:Treg crosstalk improves the efficacy of PD-1 immunotherapy. Cancer Cell. 2024;42(6):1051–1066.e7.Ethics Approval This stud…
… modulating the host immune system and influencing responses to anticancer therapies. Recent studies have highlighted the presence of complex microb…
… peptides and their cell of origin restriction may inform novel immunotherapy targets, and the relationship between endogenous and XPT peptid…
… a leading cause of cancer-related mortality globally. Although chemotherapy and targeted therapies provide clinical benefits, their efficac…
…ismatch repair-proficient (MMRp) ‘cold’ tumors, unresponsive to PD-1 blockade monotherapy. In contrast, patients with MMR-deficient (MMRd) ‘hot’ tumors e…